Development of a CD123xCD3 bispecific antibody to treat acute myeloid leukemia (AML)

被引：0
|
作者：
Gaudet, Francois
Nemeth, Jennifer F.
McDaid, Ronan
Li, Yingzhe
Harman, Benjamin
Millar, Hillary
Teplyakov, Alexey
Wheeler, John
Luo, Jinquan
Tam, Susan
Wu, Sheng-Jiun
Chen, Emily
Babich, Alexander
Elsayed, Yusri
Attar, Ricardo
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1492
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1492
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Development of a CD123xCD3 Bispecific Antibody (JNJ-63709178) for the Treatment of Acute Myeloid Leukemia (AML)
    Gaudet, Francois
    Nemeth, Jennifer F.
    McDaid, Ronan
    Li, Yingzhe
    Harman, Benjamin
    Millar, Hillary
    Teplyakov, Alexey
    Wheeler, John
    Luo, Jinquan
    Tam, Susan
    Wu, Sheng-Jiun
    Chen, Emily
    Rudnick, Stephen
    Chu, Gerald
    Hughes, Anna
    Luistro, Leopoldo
    Chin, Diana
    Babich, Alexander
    Kalota, Anna
    Singh, Indrajeet
    Salvati, Mark
    Elsayed, Yusri
    Attar, Ricardo M.
    BLOOD, 2016, 128 (22)
  • [2] Phase 1 Cohort Expansion of Flotetuzumab, a CD123xCD3 Bispecific Dart® Protein in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Uy, Geoffrey L.
    Rettig, Michael P.
    Vey, Norbert
    Godwin, John
    Foster, Matthew C.
    Rizzieri, David A.
    Arellano, Martha L.
    Topp, Max S.
    Huls, Gerwin
    Jongen-Lavrencic, Mojca
    Martinelli, Giovanni
    Paolini, Stefania
    Ciceri, Fabio
    Carrabba, Matteo Giovanni
    Sweet, Kendra L.
    Ravandi, Farhad
    Church, Sarah E.
    Vadakekolathu, Jayakumar
    Rutella, Sergio
    Sun, Jichao
    Yang, Kang
    Baughman, Jan
    Curtis, Teia
    Timmeny, Erin
    Cali, Kerri
    Tran, Kathy
    Muth, John
    La Motte-Mohs, Ross
    Poirot, Camille
    Pallis, Athanasios
    Cesano, Alessandra
    Bonvini, Ezio
    Wigginton, Jon
    Lowenberg, Bob
    Davidson-Moncada, Jan K.
    DiPersio, John F.
    BLOOD, 2018, 132
  • [3] Immune Senescence and Exhaustion Correlate with Response to Flotetuzumab, an Investigational CD123xCD3 Bispecific Dart® Molecule, in Acute Myeloid Leukemia
    Vadakekolathu, Jayakumar
    Yau, Tung On
    Church, Sarah E.
    Rettig, Michael P.
    Aldoss, Ibrahim
    Uy, Geoffrey L.
    Vey, Norbert
    Emadi, Ashkan
    Sayre, Peter H.
    Walter, Roland B.
    Foster, Matthew C.
    Arellano, Martha L.
    Godwin, John E.
    Wieduwilt, Matthew J.
    Byrne, Michael T.
    Michaelis, Laura C.
    Stiff, Patrick J.
    Carrabba, Matteo Giovanni
    Chevalier, Patrice
    Gyan, Emmanuel
    Recher, Christian
    Advani, Anjali S.
    Wermke, Martin
    Erba, Harry P.
    Ciceri, Fabio
    Huls, Geert
    Jongen-Lavrencic, Mojca
    Ravandi, Farhad
    Curti, Antonio
    Topp, Max S.
    Muth, John
    Kaminker, Patrick
    Lowenberg, Bob
    Gojo, Ivana
    Luznik, Leo
    DiPersio, John F.
    Davidson-Moncada, Jan K.
    Rutella, Sergio
    BLOOD, 2020, 136
  • [4] Engineering a CD123xCD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells
    Kuo, Shu-Ru
    Wong, Lucas
    Liu, Jen-Sing
    PROTEIN ENGINEERING DESIGN & SELECTION, 2012, 25 (10): : 561 - 569
  • [5] Novel CD123xCD3 bispecific IgM antibody, IGM-2537, potently induces T-cell mediated cytotoxicity of acute myeloid leukemia cells with minimal cytokine release
    Li, Gene
    Wang, Ling
    Yakkundi, Poonam
    Hinton, Paul
    Pandya, Deepal
    Sekar, Keerthana
    Rosete, Rodine
    Ye, Zhongde
    Hanna, Nardeen
    Kotturi, Maya F.
    Bogaert, Liz
    Hong, Jiyoung
    Tsai, Christina
    Manley, Thomas
    Keyt, Bruce A.
    Sinclair, Angus M.
    Liu, Liqin
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Ex Vivo Activity Profile of the CD123xCD3 Duobody® Antibody JNJ-63709178 Against Primary Acute Myeloid Leukemia Bone Marrow Samples
    Forslund, Ann
    Syed, Khaja
    Axel, Amy
    McDaid, Ronan
    Li, Yingzhe
    Ballesteros, Juan
    Gaudet, Francois
    Attar, Ricardo M.
    Salvati, Mark
    Huang, Fei
    Sasser, Kate
    BLOOD, 2016, 128 (22)
  • [7] Novel CD123xCD3 Bispecific Igm Antibody, Igm-2537, Potently Induces T-Cell Mediated Cytotoxicity of Acute Myeloid Leukemia Cells In Vivo and in Vitro with Minimal Cytokine Release
    Li, Gene
    Ye, Zhongde
    Yakkundi, Poonam
    Manlusoc, Marigold
    Logronio, Kathryn
    Tahrani, Leyla
    Rosete, Rodnie
    Bernados, David
    Hinton, Paul
    Pandya, Deepal
    Hanna, Nardeen
    Anantam, Jey
    Kotturi, Maya F.
    Bogaert, Liz
    Hong, Jiyoung
    Tsai, Christina
    Manley, Thomas
    Keyt, Bruce A.
    Sinclair, Angus M.
    Liu, Liqin
    BLOOD, 2023, 142
  • [8] Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123xCD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Vadakekolathu, Jayakumar
    Minden, Mark D.
    Hood, Tressa
    Church, Sarah E.
    Reeder, Stephen
    Altmann, Heidi
    Sullivan, Amy H.
    Viboch, Elena J.
    Patel, Tasleema
    Ibrahimova, Narmin
    Warren, Sarah E.
    Arruda, Andrea
    Schmitz, Marc
    Liang, Yan
    Cesano, Alessandra
    Pockley, A. Graham
    Valk, Peter
    Lowenberg, Bob
    Bornhauser, Martin
    Tasian, Sarah K.
    Rettig, Michael P.
    Davidson-Moncada, Jan K.
    DiPersio, John F.
    Rutella, Sergio
    BLOOD, 2019, 134
  • [9] Development of an IgG based, bispecific antibody with FLT3xCD3-specificity for the treatment of myeloid leukemia
    Vogt, F.
    Ehnes, I.
    Pfluegler, M.
    Bhring, H. -J.
    Salih, H.
    Jung, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 9 - +
  • [10] Preclinical activity and safety of MGD006, a CD123xCD3 Bispecific DART® molecule for the treatment of hematological malignancies
    Moore, P.
    Chichili, G. R.
    Huang, L.
    Li, H.
    Burke, S.
    Chen, F.
    He, L.
    Tang, Q.
    Jin, L.
    Gorlatov, S.
    Ciccarone, V.
    Koenig, S.
    Shannon, M.
    Alderson, R.
    Johnson, S.
    Bonvini, E.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 48 - 48
12345